We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.

The 2018 assisi think tank meeting on breast cancer: International expert panel white paper

Franco P.;
2020

Abstract

We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.
151
102967
1
15
Breast cancer; Breast reconstruction; De-escalating therapy; Ductal carcinoma in situ; Hypofractionation; Neoadjuvant chemotherapy; Partial breast irradiation; Post-mastectomy radiation therapy; Radiation therapy; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Humans; Mastectomy; Mastectomy, Segmental; Radiotherapy, Adjuvant
Arenas M.; Selek U.; Kaidar-Person O.; Perrucci E.; Montero Luis A.; Boersma L.; Coles C.; Offersen B.; Meattini I.; Bolukbasi Y.; Leonardi M.C.; Pfeffer R.; Cutuli B.; Vidali C.; Franco P.; Kouloulias V.; Masiello V.; Rivera S.; Bourgier C.; Ciabattoni A.; Lancellotta V.; Trigo L.; Valentini V.; Poortmans P.; Aristei C.
File in questo prodotto:
File Dimensione Formato  
in press.pdf

Accesso riservato

Descrizione: pdf editoriale
Tipo di file: PDF EDITORIALE
Dimensione 623.81 kB
Formato Adobe PDF
623.81 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1749831
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact